These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 653585)

  • 1. [Podagra and hyperlipemia. Effect of excessive weight on the level of circulating lipids (examination of 90 patients with podagra and 90 controls selected by the age and weight index)].
    Rond'e Zh; Truffer Zh; Le Go A; Keila Zh; Khila A
    Ter Arkh; 1978; 50(3):118-24. PubMed ID: 653585
    [No Abstract]   [Full Text] [Related]  

  • 2. Gout and hyperlipidaemia. Effect of overweight on the levels of circulating lipids.
    Rondier J; Truffert J; le Gô A; Cayla J; Hila A; de Gennes JL; Delbarre F
    Ann Clin Res; 1977 Aug; 9(4):239-45. PubMed ID: 616208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indicators of lipid metabolism in patients with podagra].
    Siniachenko OV; Nikolenko IuI; Diadyk AI; Oberemchenko IaV; Maiakova OM
    Vrach Delo; 1985 Mar; (3):55-7. PubMed ID: 4013164
    [No Abstract]   [Full Text] [Related]  

  • 4. [Liver involvement in podagra].
    Bobokhodzhaev MKh; Shukurova SM; Shifrina MM
    Ter Arkh; 1991; 63(2):64-8. PubMed ID: 2048026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relation of blood pressure to the body weight index and to metabolic parameters].
    Haller H; Leonhardt W; Moser W; Hanefeld M
    Z Gesamte Inn Med; 1973 Jul; 28(14):Suppl:211-3. PubMed ID: 4728091
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of benzbromarone on hyperlipidemia in gout].
    Marinchev L; Kŭnev K
    Vutr Boles; 1990; 29(5):99-102. PubMed ID: 2080622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipid disorders in gout and hyperuricemias].
    Roux H; Vovan L; Dutertre P; Serratrice G; Recordier AM
    Rev Rhum Mal Osteoartic; 1973 Feb; 40(2):95-105. PubMed ID: 4705340
    [No Abstract]   [Full Text] [Related]  

  • 8. [Insulin resistance syndrome in patients with gout and its influence on formation of clinical characteristics of the disease].
    Barskova VG; Eliseev MS; Nasonov EL; Iakunina IA; Zilov AV; Il'inykh EV
    Ter Arkh; 2004; 76(5):51-6. PubMed ID: 15230133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the influence of Anturan on ric acid and plasma lipids in patients with gout].
    Günther R; Herbst M; Knapp E; Siller K
    Wien Klin Wochenschr; 1968 Jun; 80(24):473-8. PubMed ID: 5692866
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of triglyceridemia, lipemia, glycemia and weight index in patients with high and normal serum uric acid].
    Kuntz D; Rouques C; Paolaggi F; Ryckewaert A
    Pathol Biol (Paris); 1969 Apr; 17(7):399-403. PubMed ID: 4893908
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect and severity of obesity on serum lipids and serum uric acid].
    Ewald W
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():820-1. PubMed ID: 1029291
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of overall adiposity rather than body mass index with lipids and procoagulant factors.
    De Lorenzo F; Mukherjee M; Kadziola Z; Suleiman S; Kakkar VV
    Thromb Haemost; 1998 Oct; 80(4):603-6. PubMed ID: 9798978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The interrelation between obesity, hyperinsulinism and hyperuricemia].
    Uccella R
    Minerva Med; 1975 Apr; 66(27):1287-94. PubMed ID: 1128797
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lipid electrophoretic changes in the serum of patients with gout].
    Pristautz H; Klein G
    Z Rheumaforsch; 1972; 31(5):238-42. PubMed ID: 5048147
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lipids and arteriosclerosis].
    Carmena R
    Rev Clin Esp; 1973 Aug; 130(3):181-94. PubMed ID: 4201566
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gout, diabetes mellitus and fatty liver].
    Mertz DP
    Munch Med Wochenschr; 1972 Feb; 114(5):180-5. PubMed ID: 5066917
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
    Dujovne CA; Zavoral JH; Rowe E; Mendel CM;
    Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frequency and distribution of hyperlipoproteinemias in arterial diseases, diabetes, and gout. Results of 20 examinations carried out in a hospital setting].
    Vovan L; Lena D; Colombani V; Magnet C
    Ann Biol Clin (Paris); 1973; 31(2):151-2. PubMed ID: 4749232
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperlipemia in the rural population of Portugal].
    Pereira-Miguel MJ; Halpern M; Pereira-Miguel JM; Amador MG; Filipe da Silva J; Lima M; de Padua F
    Ann Biol Clin (Paris); 1973; 31(2):147-8. PubMed ID: 4749230
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood lipids profile in obese or overweight patients.
    Szczygielska A; Widomska S; Jaraszkiewicz M; Knera P; Muc K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):343-9. PubMed ID: 15323217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.